Antifungals: mechanism of action and resistance, established and novel drugs
- 1 October 1998
- journal article
- review article
- Published by Elsevier BV in Current Opinion in Microbiology
- Vol. 1 (5), 547-557
- https://doi.org/10.1016/s1369-5274(98)80087-8
Abstract
No abstract availableKeywords
This publication has 122 references indexed in Scilit:
- Therapy of deep fungal infection in haematological malignancy. Working Party of the British Society for Antimicrobial ChemotherapyJournal of Antimicrobial Chemotherapy, 1997
- Identification of Yeast Rho1p GTPase as a Regulatory Subunit of 1,3-β-Glucan SynthaseScience, 1996
- Translation elongation factor-3 (EF-3): An evolving eukaryotic ribosomal protein?Journal of Molecular Evolution, 1995
- Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungalsCurrent Genetics, 1995
- Critical steps in fungal cell wall synthesis: Strategies for their inhibitionPharmacology & Therapeutics, 1993
- Anti-Candida Activity of Cispentacin: The Active Transport by Amino Acid Permeases and Possible Mechanisms of ActionBiochemical and Biophysical Research Communications, 1993
- Candida albicansand three otherCandidaspecies contain an elongation factor structurally and functionally analogous to elongation factor 3FEMS Microbiology Letters, 1991
- The mechanism of antifungal action of (S)-2-amino-4-oxo-5-hydroxypentanoic acid, RI-331: The inhibition of homoserine dehydrogenase in Saccharomyces cerevisiaeBiochemical and Biophysical Research Communications, 1990
- The GalbonolidesAnnals of the New York Academy of Sciences, 1988
- In-vitro effect of itraconazole, ketoconazole and amphotericin B on the phagocytic and candidacidal function of human neutrophilsJournal of Antimicrobial Chemotherapy, 1986